CANCER NOMENKLATURE AND SUSTAINED PROLIFERATIVE SIGNALING

Authors

  • Raxmonov Shoxzodbek Oybek o’g’li Assistant of the Department of Pathology and Forensic Medicine, Central Asian Medical University Andijan State Medical Institute, 2nd Year Clinical Supervisor, "Laboratory Work" Course

Keywords:

Cancer, rhabdomyosarcoma, guanine diphosphate (GDP), epidermal growth factor (EGF), guanine triphosphate (GTP).

Abstract

Cancer is a leading cause of suffering and death in the developed world. It is now understood that cancer is a collection of more than 100 different diseases, each caused by a specific and often unique age-related accumulation of genetic and epigenetic alterations. Environment, heredity, and behavior interact to modify the risk of developing cancer and the response to treatment. Improvements in treatment strategies and supportive care, coupled with new, often individualized therapies based on advances of the basic pathophysiology of malignancy, have contributed to an increasing number of effective options for these diverse, often lethal disorders collectively called cancer.

Downloads

Published

2025-02-25

How to Cite

Raxmonov Shoxzodbek Oybek o’g’li. (2025). CANCER NOMENKLATURE AND SUSTAINED PROLIFERATIVE SIGNALING. Web of Medicine: Journal of Medicine, Practice and Nursing, 3(2), 413–417. Retrieved from http://webofjournals.com/index.php/5/article/view/3397

Issue

Section

Articles